---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-007260"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2024-06-03T23:59:59+00:00"
generated_at: "2026-06-01T06:51:34.902636+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CEO loans Catheter Precision $500K at 8%; enters royalty agreement for LockeT device

## Summary
- CEO David Jenkins loaned $500,000 via 8% promissory note due August 30, 2024.
- Royalty agreement with co-inventor Auston Locke: 5% net sales of LockeT device until $1M, then 2% up to $10M; ends Dec 31, 2033 or patent expiry.
- Jenkins and affiliates hold >10% common stock, Series X preferred convertible into >8M shares, and 11.77% royalty on LockeT sales.
- Missiaen Huck, Jenkins' adult daughter, serves as non-executive COO.

## SEC filing metadata
- accession: 0001654954-24-007260
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2024-06-03T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000165495424007260/0001654954-24-007260-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000165495424007260/rmed_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-007260
- JSON: https://secwatch.observer/filing/0001654954-24-007260.json
- Plain text: https://secwatch.observer/filing/0001654954-24-007260.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.